Synthesis and leishmanicidal activity of quinoline-triclosan and quinoline-eugenol hybrids

Medicinal Chemistry Research

Volumn 21, Issue 11, 2012, Pages 3445-3454

  Arango, Victor ^a   Domínguez, Jorge J ^a   Cardona, Wilson ^a   Robledo, Sara M ^a   Muñoz, Diana L ^a   Figadere, Bruno ^b   Sáez, Jairo ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b CNRS   (France)

Author keywords

Amastigotes; Antiprotozoal; Eugenol; Hybrids; Leishmania; Quinoline; Triclosan

Indexed keywords

8 [3 [5 [CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]PROPYL]OXY] 2 METHYLQUINOLINE; 8 [[12 (4 ALLYL 2 METHOXYPHENOXY)DODECYL]OXY] 2 METHYLQUINOLINE; 8 [[12 [5 CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]DODECYL]OXY] 2 METHYLQUINOLINE; 8 [[3 (4 ALLYL 2 METHOXYPHENOXY)PROPYL]OXY] 2 METHYLQUINOLINE; 8 [[4 (4 ALLYL 2 METHOXYPHENOXY)BUTYL]OXY] 2 METHYLQUINOLINE; 8 [[4 [5 CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]BUTYL]OXY] 2 METHYLQUINOLINE; 8 [[5 (4 ALLYL 2 METHOXYPHENOXY)PENTYL]OXY] 2 METHYLQUINOLINE; 8 [[5 [5 CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]PENTYL]OXY] 2 METHYLQUINOLINE; 8 [[8 (4 ALLYL 2 METHOXYPHENOXY)OCTYL]OXY] 2 METHYLQUINOLINE; 8 [[8 [5 CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]OCTYL]OXY] 2 METHYLQUINOLINE; 8 [[9 (4 ALLYL 2 METHOXYPHENOXY)NONYL]OXY] 2 METHYLQUINOLINE; 8 [[9 [5 CHLORO 2 (2,4 DICHLOROPHENOXY)PHENOXY]NONYL]OXY] 2 METHYLQUINOLINE; AMPHOTERICIN B; ANTILEISHMANIAL AGENT; MEGLUMINE ANTIMONATE; QUINOLINE; TRICLOSAN; UNCLASSIFIED DRUG;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; IN VITRO STUDY; LC 50; NONHUMAN; WILLIAMSON REACTION;

EID: 84871460204     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9886-8     Document Type: Article

References (44)

1. Akendengue B, Ngou-Milama E, Laurens A, Hocquemiller R (1999) Recent advances in the fight against leishmaniasis with natural products. Parasite 6:3-8
2. Antoine JC, Jouanne C, Ryter A (1989) Megasomes as the targets of leucine methyl ester in Leishmania amawnensis amastigotes. Parasitol 99:1-9
3. Ayad F, Tilley L, Deady L (2001) Synthesis, antimalarial activity and inhibition of haem detoxification of novel bisquinolines. Bioorg Med Chem Lett 11:2075-2077
4. Bhargava HN, Leonard PA (1996) Triclosan: Applications and safety. Am J Infect Control 24:209-218
5. Bollini M, Casal J, Bruno A (2008) Design, synthesis, and antitumor activity of new bis-Aminomethylnaphthalenes. Bioorg Med Chem 16:8003-8010
6. Chaudhuri P, Majumder H, Bhattacharya S (2007) Synthesis, DNA binding, and Leishmania topoisomerase inhibition activities of a novel series of anthra[1, 2-d]imidazole-6, 11-dione derivatives. J Med Chem 50:2536-2540
7. Chhibber M, Kumar G, Parasuraman P, Ramya TNC, Surolia N, Surolia A(2006) Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Bioorg Med Chem 14:8086-8098
8. Croft SL, Coombs GH (2003) Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19:502-508
9. Dade J, Provot O, Moskowitz H, Mayrargue J, Prina E (2001) Synthesis of 2-substituted trifluoromethylquinolines for the evaluation of leishmanicidal activity. Chem Pharm Bull 49:480-483
10. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27:305-318
11. Dietze R, Carvalho SF, Valli LC, Berman J, Brewer T, Milhous W, Sanchez J, Schuster B, Grogl M (2001) Phase 2 trial of WR6026, an orally administered 8-Aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi. Am J Trop Med Hyg 65:685-689
12. Dillard RD, Pavey DE, Benslay DN (1973) Synthesis and antiinflammatory activity of some 2,2-dimethyl-1,2-dihydroquinolines. J Med Chem 16:251-253
13. Doube D, Blouin M, Brideau C, Chan C, Desmarais C, Ethier D, Falgueyret JP, Friesen RW, Girard M, Girard Y, Guay J, Tagari P, Young RN (1998) Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746, 530. Bioorg Med Chem Lett 8:1255-1260
14. Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugere B, Dumon H (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41:827-830
15. Finney JD (1971) Probit analysis, 3rd edn. Cambridge University Press, Cambridge
16. Fournet A, Ferreira ME, Arias ARD, De Ortiz ST, Fuentes S, Nakayama H, Schinini A, Hocquemiller R (1996) In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob Agents Chemother 40:2447-2451
17. Freundlich JS, Anderson JW, Sarantakis D, Shieh H, Yu M, Valderramos J, Lucumi E, Kuo M, Jacobs WR, Schiehser GA, Fidock DA, Jacobus DP, Sacchettini JC (2005) Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 40-substituted triclosan derivatives. Bioorg Med Chem Lett 15:5247-5252
18. Freundlich JS, Yu M, Lucumi E, Kuo M, Tsai H, Valderramos J, Karagyozov L, Jacobs WR, Schiehser GA, Fidock DA, Jacobus DP, Sacchettini JC (2006) Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 20-substituted triclosan derivatives. Bioorg Med Chem Lett 16:2163-2169
19. Freundlich JS, Wang F, Tsai H, Kuo M, Shieh H, Anderson JW, Nkrumah LJ, Valderramos J, Yu M, Kumar TRS, Valderramos SG, Jacobs WR, Schiehser GA, Jacobus DP, Fidock DA, Sacchettini JC (2007) X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy. J BiolChem 282:25436-25444
20. Kapoor M, Reddy C, Krishnasastry MV, Surolia N, Surolia A (2004) Slow-tight-binding inhibition of enoyl-Acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem J 381:719-724
21. Keith CT, Borisy A, Stockwell BR (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4:71-78
22. Kidwai M, Bhushan KR, Sapra P, Saxena RK, Gupta R (2000) Alumina-supported synthesis of antibacterial quinolines using microwaves. Bioorg Med Chem 8:69-72
23. McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW (2001) Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol 31:109-113
24. Meunier B (2008) Hybrid molecules with a dual mode of action: dream or reality Acc Chem Res 41:69-77
25. Mohammed AF, Fournet A, Prina E, Mouscadet JF, Franck X, Hocquemiller R, Figadere B (2003) Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and retroviral co-infections. Bioorg Med Chem 11: 5013-5023
26. Musonda C, Whitlock G, Witty M, Brun R, Kaiser M (2009) Chloroquine-Astemizole hybrids with potent in vitro and in vivo antiplasmodial activity. Bioorg Med Chem Lett 19:481-484
27. Nakamura TU, Mendonca-Filho R, Morgado J, Korehisa P et al (2006) Antileishmanial activity of eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int 55:99-105
28. Nakayama H, Loiseau PM, Bories C, de Ortiz ST, Schinini A, Serna E, de Arias AR, Mohamed AF, Franck X, Figadere B, Hocquemiller R, Fournet A (2005) Efficacy of orally administered 2-substituted quinolines in experimental Murine cutaneous and Visceral leishmaniases. Antimicrob Agents Chemother 49:4950-4956
29. Narsinh D, Anamik S (2001) Synthesis and anti-HIV studies of some substituted pyrimidinediones, ethoxy pyrano (3,2-c) quinolines and hydrazino pyrano (3,2-c) quinolines. Ind J Pharm Sci 63:211-215
30. Olliaro PL, Bryceson AD (1993) Practical progress and new drugs for changing patterns of Leishmaniasis. Parasitol Today 9:323-328
31. Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA (2008) New chimeric antimalarials with 4-Aminoquinoline moiety linked to a tetraoxane skeleton. J Med Chem 51:6216-6219
32. Ouellette M, Drummelsmith J, Papadopoulou B (2004) Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat 7:257-266
33. Palit P, Paira P, Hazra A, Banerjee S, Das Gupta A, Dastidar S, Mondal N (2009) Phase transfer catalyzed synthesis of bis-quinolines: Antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation. Eur J Med Chem 44:845-853
34. Perozzo R, Kuo M, Sidhu AbS, Valiyaveettil JT, Bittman R, JacobsWR Jr, Fidock DA, Sacchettini JC (2002) Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 277:13106-13114
35. Robledo SM, Valencia AZ, Saravia NG (1999) Sensitivity to Glucantime of Leishmania viannia isolated from patiens prior to treatment. J Parasitol 85:360-366
36. Robledo S, Osorio E, Jaramillo L (2005) In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives. Antimic Agents Chemoth 49:1652-1655
37. Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353-359
38. Surolia N, Surolia A (2001) Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase. Nat Med 7:167-173
39. Taylor VM, Munoz DL, Cedeno DL, Vélez ID, Jones MA, Robledo SM (2010) Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents. Exp Parasitol 126:471-475
40. Tempone A, Melo A, Da Silva P, Brandt C, Martinez F, Borborema A (2005) Synthesis and antileishmanial activities of novel 3-substituted quinolines. Antimicrob Agents Chemother 49:1076-1080
41. Varela MRE, Munoz DL, Robledo SM, Kolli BK, Dutta S, Chang KP, Muskus C (2009) Leishmania (Viannia) panamensis: An in vitro assay using the expression of GFP for screening of antileishmanial drug. Exp Parasitol 122:134-139
42. Vennerstrom JL, Ager AL Jr, Dorn A, Andersen SL, Gerena L, Ridley RG, Milhous WK (1998) Bisquinolines. 2. Antimalarial N,NBis (7-chloroquinolin-4-yl) heteroalkanediamines. J Med Chem 41:4360-4364
43. Walsh JJ, Coughlan D, Heneghan N, Gaynor C, Bell A (2007) A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg Med Chem Lett 17:3599-3602
44. Weninger B, Robledo S, Arango G, Deharo E, Aragón R, Munoz V, Callapa J, Lobstein A, Anton R (2001) Antiprotozoal activities of Colombian plants. J Ethnophar 78:193-200